C30-NBOMe
C30-NBOMe, or 30C-NBOMe, also known as N-(3,4,5-trimethoxybenzyl)-4-chloro-2,5-dimethoxyphenethylamine or as 25C-NB345OMe, is a serotonin receptor modulator of the phenethylamine, 2C, and 25-NB (NBOMe) families.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
C30-NBOMe, or 30C-NBOMe, also known as N-(3,4,5-trimethoxybenzyl)-4-chloro-2,5-dimethoxyphenethylamine or as 25C-NB345OMe, is a serotonin receptor modulator of the phenethylamine, 2C, and 25-NB (NBOMe) families. It is an analogue of 25C-NBOMe with three methoxy groups on the benzyl ring, located at the 3, 4, and 5 positions.
The drug was encountered as a novel designer drug in Sweden in 2013. However, C30-NBOMe showed greater than or equal to 1,000-fold lower potency as a serotonin 5-HT 2A receptor agonist in vitro compared to conventional 25-NB drugs like 25I-NBOMe and 25B-NBOMe ( = 1,251 nM vs. 0.40–1.2 nM, respectively).
Its affinity for the serotonin 5-HT 2A receptor was similarly low (K i = 515 nM, versus 0.82 nM for 25C-NBOMe). The chemical identification of C30-NBOMe has been studied and described.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1359027560 under CC BY-SA 4.0; modifications have been made.